These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 29606986

  • 1. Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now?
    Marek-Bukowiec K, Konieczny A, Ratajczyk K, Witkiewicz W.
    Dis Markers; 2018; 2018():5205831. PubMed ID: 29606986
    [Abstract] [Full Text] [Related]

  • 2. Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.
    Graterol F, Navarro-Muñoz M, Ibernon M, López D, Troya MI, Pérez V, Bonet J, Romero R.
    BMC Nephrol; 2013 Apr 11; 14():82. PubMed ID: 23577616
    [Abstract] [Full Text] [Related]

  • 3. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 Apr 11; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

  • 4. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
    Surin B, Sachon E, Rougier JP, Steverlynck C, Garreau C, Lelongt B, Ronco P, Piedagnel R.
    Proteomics; 2013 Jan 11; 13(1):142-52. PubMed ID: 23161552
    [Abstract] [Full Text] [Related]

  • 5. Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy.
    Mucha K, Bakun M, Jaźwiec R, Dadlez M, Florczak M, Bajor M, Gala K, Pączek L.
    Pol Arch Med Wewn; 2014 Jan 11; 124(7-8):380-6. PubMed ID: 24938435
    [Abstract] [Full Text] [Related]

  • 6. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
    Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA.
    Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053
    [Abstract] [Full Text] [Related]

  • 7. MicroRNAs in IgA nephropathy.
    Yao X, Zhai Y, An H, Gao J, Chen Y, Zhang W, Zhao Z.
    Ren Fail; 2021 Dec 10; 43(1):1298-1310. PubMed ID: 34547971
    [Abstract] [Full Text] [Related]

  • 8. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
    Neuhaus J, Bauer F, Fitzner C, Hilgers RD, Seibert F, Babel N, Doevelaar A, Eitner F, Floege J, Rauen T, Westhoff TH.
    Kidney Blood Press Res; 2018 Dec 10; 43(5):1563-1572. PubMed ID: 30347407
    [Abstract] [Full Text] [Related]

  • 9. Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.
    Rocchetti MT, Papale M, d'Apollo AM, Suriano IV, Di Palma AM, Vocino G, Montemurno E, Varraso L, Grandaliano G, Di Paolo S, Gesualdo L.
    Clin J Am Soc Nephrol; 2013 Jul 10; 8(7):1115-25. PubMed ID: 23599406
    [Abstract] [Full Text] [Related]

  • 10. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
    Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X.
    Rapid Commun Mass Spectrom; 2010 Jul 30; 24(14):1971-8. PubMed ID: 20552702
    [Abstract] [Full Text] [Related]

  • 11. The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy.
    Obara T, Mizoguchi S, Shimozuru Y, Sato T, Hotta O.
    Clin Exp Nephrol; 2012 Oct 30; 16(5):713-21. PubMed ID: 22415778
    [Abstract] [Full Text] [Related]

  • 12. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
    Duan ZY, Cai GY, Bu R, Lu Y, Hou K, Chen XM.
    Sci Rep; 2016 Mar 22; 6():23498. PubMed ID: 27000966
    [Abstract] [Full Text] [Related]

  • 13. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 14. Markers for the progression of IgA nephropathy.
    Maixnerova D, Reily C, Bian Q, Neprasova M, Novak J, Tesar V.
    J Nephrol; 2016 Aug 15; 29(4):535-41. PubMed ID: 27142988
    [Abstract] [Full Text] [Related]

  • 15. Proteomic approach for identification of IgA nephropathy-related biomarkers in urine.
    Prikryl P, Vojtova L, Maixnerova D, Vokurka M, Neprasova M, Zima T, Tesar V.
    Physiol Res; 2017 Sep 22; 66(4):621-632. PubMed ID: 28406696
    [Abstract] [Full Text] [Related]

  • 16. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.
    Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H.
    Kidney Int; 2005 Jun 22; 67(6):2313-20. PubMed ID: 15882273
    [Abstract] [Full Text] [Related]

  • 17. Application of Sparse Linear Discriminant Analysis and Elastic Net for Diagnosis of IgA Nephropathy: Statistical and Biological Viewpoints.
    Mohammadi Majd T, Kalantari S, Raeisi Shahraki H, Nafar M, Almasi A, Samavat S, Parvin M, Hashemian A.
    Iran Biomed J; 2018 Nov 22; 22(6):374-84. PubMed ID: 29523019
    [Abstract] [Full Text] [Related]

  • 18. IgA nephropathy: a clinical overview.
    Julian BA, Wyatt RJ, Matousovic K, Moldoveanu Z, Mestecky J, Novak J.
    Contrib Nephrol; 2007 Nov 22; 157():19-26. PubMed ID: 17495433
    [Abstract] [Full Text] [Related]

  • 19. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
    Ding H, He Y, Li K, Yang J, Li X, Lu R, Gao W.
    Clin Immunol; 2007 May 22; 123(2):227-34. PubMed ID: 17360238
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.
    Guo Z, Wang Z, Lu C, Yang S, Sun H, Reziw, Guo Y, Sun W, Yue H.
    BMC Nephrol; 2018 Dec 14; 19(1):358. PubMed ID: 30547763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.